// App-Quantinova.ai

Su1692 : ANALYSIS OF VARIOUS CENTRAL ENDOSCOPY READING METHODOLOGIES IN THE BERGAMOT EXPLORATORY INDUCTION COHORT EVALUATING ETROLIZUMAB IN CROHN’S DISEASE

Researchers

Presenter

  • Walter Reinisch

Principal Investigators

  • Daniel Mishkin

  • Young S. Oh

  • Stefan Schreiber

  • Romeo Maciuca

  • Rhian Jacob

  • Azra Hassanali

  • Udayasankar Arulmani

  • Marco Daperno

Medical Centers

  • Medical University of Vienna, Vienna, Austria

  • Atrius Health, Boston, MA

  • Genentech, Inc., South San Francisico, CA

  • Christian-Albrechts-University, Kiel, Germany

  • Roche Products Ltd., Welwyn Garden City, United Kingdom

  • AO Ordine Mauriziano, TORINO, Italy

Locations

  • Austria

  • United States

  • Germany

  • United Kingdom

  • Italy

Companies

  • Genentech, Inc.

  • Feng Chi Biotech Cor

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Etrolizumab

Outcome

  • N/A

Study Design

  • Placebo Control

  • Double Blind/Blinded

  • Cohort

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved